Understanding how respiratory viruses affect vulnerable populations

Systems Immunology profiling of respiratory viral infections in vulnerable populations

NIH-funded research Benaroya Research Inst at Virginia Mason · NIH-11295557

This study is looking at how the immune system reacts to respiratory viruses in older adults and people with health issues, so we can find better ways to treat them, and patients may help by sharing samples or information about their health.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBenaroya Research Inst at Virginia Mason NIH-funded
Lab location1 site (Seattle, United States)
Project IDNIH-11295557 on NIH RePORTER

What this research studies

This research investigates the immune responses to respiratory viral infections in populations that are particularly at risk, such as the elderly or those with underlying health conditions. By profiling the immune system's reaction to these infections, the study aims to identify specific biomarkers and immune pathways that could inform better treatment strategies. Patients may be involved in providing samples or data that will help researchers understand the variations in immune responses among different groups. The approach combines advanced immunological techniques with patient data to create a comprehensive picture of how these infections impact health.

Who could benefit from this research

Good fit: Ideal candidates for participation include individuals from vulnerable populations, such as the elderly or those with chronic health conditions.

Not a fit: Patients who are healthy and do not belong to vulnerable groups may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for respiratory viral infections in vulnerable populations.

How similar studies have performed: While the specific approach may be novel, similar research has shown promise in understanding immune responses to infections in at-risk populations.

Where this research is happening

Seattle, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.